Niche Consulting OBiS is a boutique pharmaceutical consulting firm with a footprint in New York and a French subsidiary, offering specialized services in business development analytics, market forecasting, clinical site profiling, and ROI analyses—potential for expanding engagements with mid to large pharma/biotech clients seeking targeted market insights.

Drug Market Focus Core offerings include new drug market forecasting and protocol feasibility analytics, presenting upsell opportunities with early-stage R&D programs and portfolio planning teams at sizable pharma companies looking to de-risk and validate development strategies.

Clinical & Site Insights Expertise in clinical site identification and recruitment projections positions OBiS to support sponsors during trial design and site selection phases, offering services to optimize trial timelines and patient enrollment for sponsors expanding global late-phase studies.

Operational Scale Signals Small team size (2-10 employees) paired with revenues in the tens of millions suggests high-margin, specialized engagements—potential to scale through targeted partnerships with larger firms or by expanding BPO-style analytics to broader commercial analytics programs.

Digital & Global Reach Presence with a France-based subsidiary and a tech stack including Google Cloud and analytics tools indicates readiness for cross-border projects; leverage this to target multinational sponsors requiring regional insights and global market intelligence.